Saol Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Saol Therapeutics's estimated annual revenue is currently $9.2M per year.
- Saol Therapeutics's estimated revenue per employee is $201,000
Employee Data
- Saol Therapeutics has 46 Employees.
- Saol Therapeutics grew their employee count by 2% last year.
Saol Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Head Regulatory | Reveal Email/Phone |
2 | SVP, Strategy | Reveal Email/Phone |
3 | VP Finance | Reveal Email/Phone |
4 | VP, Operations & Compliance | Reveal Email/Phone |
5 | QA and Regulatory Affairs Director | Reveal Email/Phone |
6 | Senior Director, Drug Product Development | Reveal Email/Phone |
7 | Medical Director | Reveal Email/Phone |
8 | Senior Director Strategic Marketing | Reveal Email/Phone |
9 | Senior Director Strategic Marketing | Reveal Email/Phone |
10 | General Manager | Reveal Email/Phone |
Saol Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $24.5M | 122 | 8% | N/A | N/A |
#2 | $10.7M | 53 | -17% | N/A | N/A |
#3 | $9.2M | 46 | 2% | N/A | N/A |
#4 | $24.1M | 120 | 5% | N/A | N/A |
#5 | $7.2M | 36 | -20% | N/A | N/A |
#6 | $27.7M | 138 | -30% | N/A | N/A |
#7 | $39.8M | 198 | 37% | N/A | N/A |
#8 | $0.5M | 5 | 25% | $50M | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $10.3M | 51 | 11% | N/A | N/A |
What Is Saol Therapeutics?
Saol Therapeutics (pronounced ?Sail??) is a privately held specialty pharmaceutical company focused on providing therapies to patients with rare diseases. The company has a strategic emphasis on the neurology therapeutic area. For more information, please visit our website: www.saolrx.com.
keywords:N/AN/A
Total Funding
46
Number of Employees
$9.2M
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Saol Therapeutics News
2022-04-20 - Amneal Scores Second US Biosimilar Approval With Avastin ...
Amneal says an $83.5m deal to acquire Saol Therapeutics' baclofen franchise will also bring the firm an experienced institutional...
2022-03-22 - Saol Therapeutics and GeneDx, Inc. Collaborate to Detect ...
Saol is focused on clinical development activity in rare diseases, with a focus on mitochondrial disorders, as well as central nervous system...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $14.7M | 46 | -6% | N/A |
#2 | $10.2M | 47 | 9% | N/A |
#3 | $5.5M | 47 | 2% | N/A |
#4 | $12.4M | 47 | 0% | N/A |
#5 | $15M | 48 | 4% | N/A |